Nice, I like these two statements Leronlimab i
Post# of 148182
Quote:
Leronlimab is a platform technology drug and they could see a minimum of 2 to 4 BTD’s in the coming year.
BTD Pure Plays
The reason the list of pure plays is so small is because a little less than half got swallowed up by big pharma. All the companies with 2 or more BTD were gobbled up by big pharma. . This list essentially represents low hanging fruit for a Big Pharma acquisition. Any company with 2 or more BTD’s would be in the hot zone for acquisition. Dissecting this list, the companies with the lowest market capitalization were targeting disease indications that represent small patient populations.